TrialsgrambetaRCTs are beautiful

WAKE-UP

2018

MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset

In 503 patients with ischaemic stroke of unknown onset and DWI–FLAIR mismatch, alteplase improved mRS 0–1 at 90 days versus placebo.

Result

Efficacy: mRS 0–1 at 90 daysadj. OR 1.61 (95% CI 1.09-2.36) · P = 0.02

Below 1 favours placebo, above 1 favours alteplase.

Event rates
Absolute difference
11.5 points
NNT
9

Absolute difference and NNT are derived from the event rates.

Also reported: Numerically higher mortality with alteplase.

Original publication
Subtopic
MRI-guided lysis
Design
Double-blind RCT; stopped early due to funding
Relevance
Important: one of several pillars.
Source
Thomalla G, et al. N Engl J Med. 2018;379(7):611-622.doi 10.1056/NEJMoa1804355

Discussion & critique

Enables MRI-selected thrombolysis in wake-up stroke.

Discussed in podcasts